Caregiver Burden clinical trials

Explore recruiting caregiver burden clinical trials.

Recruiting caregiver burden studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Caregiver Burden trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms of Radiprodil in Patients with Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD) Type II.

Spain, Poland, Italy, Netherlands, Belgium

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Long-term, Open-label Extension Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Germany, Spain, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

INITIATE-LECIG: Intestinal levodopa + entacapone therapy (Lecigon®) to counteract dopaminergic desensitization and neuropsychiatric complications in Parkinson’s disease

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Double-blind, randomized, placebo-controlled study of Leriglitazone in pediatric Rett Syndrome

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label Study to Assess the Long-Term Safety and Tolerability of ML-007C-MA in Adult Participants with Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

Italy, Poland, Czechia, Portugal, Bulgaria, France +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages. Effect of CAFeine on Cognition in Alzheimer's Disease ( CAFCA )

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Caregiver Burden trials by city

Caregiver Burden in Toronto Caregiver Burden in Vancouver Caregiver Burden in Montreal Caregiver Burden in Calgary Caregiver Burden in Edmonton Caregiver Burden in Ottawa Caregiver Burden in Winnipeg Caregiver Burden in Quebec City Caregiver Burden in Hamilton Caregiver Burden in Kitchener Caregiver Burden in London Caregiver Burden in Halifax Caregiver Burden in New York Caregiver Burden in Los Angeles Caregiver Burden in Chicago Caregiver Burden in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease